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Abstract
Reversible Myocardial Dysfunction in a Rodent Model of Prenatal Stress

Jessalyn Marie Hadfield

Compelling clinical reports indicate that emotional/behavioral stress alone is sufficient to
cause profound, but completely reversible myocardial dysfunction in selected individuals. A
rodent cardiomyopathy model was previously reported by combining pre-natal and post-natal
behavioral/restraint stress (Stress). A decrease in % FS (the ratio between the diameter of the left
ventricle when it is relaxed and when it is contracted) by echocardiogram was previously
reported, along with both systolic and diastolic dysfunction by catheter-based hemodynamics, as
well as attenuated hemodynamic and inotropic responses to the beta adrenergic agonist,
isoproterenol (ISO) in Stress compared with matched Controls. The p38mitogen-activated
protein (MAP) kinase inhibitor, SB203580, both prevented and reversed the baseline reduction in
systolic and diastolic dysfunction, as well as the blunted ISO response in cardiac myocytes from
Stress animals in vitro and in vivo. p38 MAP kinase has been reported to be activated by
oxidative stress. Previous work showed that the sulhydryl donor and substrate for glutathione, Nacetylcysteine (NAC), reversed myocardial dysfunction in 2 different genetic proteinopathy
models (Syrian Hamster and Tat mouse). In the current studies, cardiac myocytes isolated from
Stress revealed evidence of mitochondrial dysfunction and oxidative stress as indicated by
decreased ATP concentration and decreased GSH/GSSG ratio, respectively. Stress cardiac
myocytes also displayed blunted inotropic and [Ca2+]i responses to extracellular Ca2+ ([Ca2+]out)
and ISO (p<0.05, for each), as well as altered inotropic responses to the intracellular calcium
regulator, caffeine (10mM),which causes sacroplasmic reticulum Ca2+ depletion (p<0.01).
Treatment of cardiac myocytes with NAC (10-3 M) normalized calcium handling in response to
ISO and [Ca2+]out and inotropic response to caffeine (p<0.01, for each). NAC also normalized
the blunted inotropic response to ISO and Ca2+ (p<0.01, for each). Surprisingly, NAC did not
reverse the changes in GSH, GSSG or GSH/GSSG ratio. These data indicate that NAC may
reverse cardiac myocyte dysfunction by a glutathione-independent effect on intracellular calcium
signaling. Elucidating the molecular mechanisms responsible for the salutary effects of NAC
may provide novel insights into potential therapeutic targets for the reversal of myocardial
dysfunction in patients with cardiomyopathies and heart failure.
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Introduction
A considerable body of literature supports an important relationship between chronic
mood disorders (e.g. depression, anxiety) and adverse outcomes from heart disease. These results
also indicate that depression mediates adverse effects on patients through mechanisms other than
poor compliance to medical therapy or increases in risk factors, such as smoking. An intriguing
possibility is that mood disorders and heart disease interact through a more fundamental,
biological mechanism. In an effort to understand the molecular mechanisms involved, our lab
developed an animal model for co-morbid mood disorders and heart disease using Birkle’s
prenatal stress (PS) rat model (Cratty et al,1995).

PS has gained widespread acceptance as an animal model for chronic behavioral stress
and mood disorders in humans. PS rats share important characteristic behavioral, anatomical and
biochemical features with humans suffering from post-traumatic stress disorder (PTSD) and
major depressive disorder (MDD) (Fride and Weinstock, 1988; Weinstock and Fride, 1988;
Takahashi et al,1988; Takahashi et al, 1990; Fride et al, 1986; Weinstock et al, 1998; Cratty et
al,1995; Weinstock 1997; Coplan et al, 1995). PS rats from Birkle’s lab revealed no significant
echocardiographic or hemodynamic changes from control rats at 6 weeks of age. However,
further behavioral stress alone in PS resulted in both systolic and diastolic myocardial
dysfunction and beta adrenergic desensitization in vivo and cardiac myocyte dysfunction in vitro.
Inhibition of p38 mitogen activated protein kinase (MAPK) phosphorylation both prevented and
reversed the myocardial dysfunction and adrenergic desensitization in vivo and in vitro. Being a
stress-activated protein kinase, p38 MAPK is activated by oxidative stress. This result indicates a
pathogenic role for enhanced oxidative stress in the myocardial dysfunction in these behaviorally
stressed animals. Finkel et al (1993) previously reported indirect evidence for reversal of
myocardial dysfunction by redox mediated regulation of the cardiac sarcoplasmic reticulum
calcium release channel, ryanodine receptor (RyR2). Therefore, we now studied the molecular
mechanisms linking oxidative stress and RyR2 to reversible myocardial dysfunction following
behavioral stress.

1

Review of Literature

Mood Disorders and Heart Disease:
A substantial body of literature supports an important relationship between chronic mood
disorders (e.g. depression, anxiety) and adverse outcomes from heart disease (Black, 1998; Sutor
et al, 1998; Lauzon et al, 2003; Pignay-Demaria et al, 2003). Depressed individuals are more
likely to develop heart disease in the first place, and they are more likely to die once they are
diagnosed with it (Anda et al, 1993; Barefoot et al, 1996; Frasure-Smith, 1993; Frasure-Smith,
1995). Epidemiologic studies initially appeared to provide lifestyle explanations for the adverse
impact of depression on the development and progression of heart disease (Glassman et al, 1990;
Ziegelstein et al,2000; Blumenthal et al,1982; Carney et al, 1995; DiMatteo et al, 2002; Guck et
al, 2003; Carney et al, 1993; Khanna et al, 2006). However, multivariate analyses indicate that
co-morbid depression is an independent risk factor for increased cardiac death in patients with
heart disease (Frasure-Smith et al, 1993; Frasure-Smith et al, 1995; Lesperance et al, 2002;
Glassman et al, 2002). Clinical data also indicate that depression mediates adverse effects on
patients through mechanisms other than poor compliance to medical therapy or increases in risk
factors, such as smoking (Lesperance et al, 2002; Glassman et al, 2002). An intriguing possibility
is that mood disorders and heart disease interact through a more fundamental, biological
mechanism.
Our lab collaborated with Dale Birkle, PhD to develop an animal model for heart disease
and depression, using her prenatally stressed rat model (PS) (Cratty et al, 1995). This model
exhibited myocardial dysfunction following behavioral stress alone, without any of the other
known mechanical, chemical or infectious insults. Reports supporting the clinical relevance of an
association between acute behavioral stress alone and myocardial dysfunction appeared in

2

studies of “stress-induced”, “Takotsubo” or “Broken Heart” cardiomyopathy (Akashi et al, 2008;
Kurisu et al, 2002; Wittstein et al, 2005; Sharkey et al, 2005). Characteristics of this pathology
include close temporal association with behavioral stress, complete reversibility within weeks
and elevated circulating catecholamines. Although “Takotsubo” cardiomyopathy is mainly
described in post-menopausal women, it is likely that more cases of stress-induced
cardiomyopathy and reversible myocardial dysfunction will emerge clinically (Khanna et al,
2006; Kan and Finkel, 2003; Bybee and Prasad et al, 2008; Richard, 2011).
Oxidative Stress:
Oxidative stress is one potential biologic mechanism relating behavioral stress to
adverse cardiovascular outcomes (Jones, 2008; Akki et al, 2009; Masood et al, 2008; Bouayed
et al, 2007; Liu et al, 1996; Liu et al, 2003; Nadeem et al, 2006; Ahlbom et al, 2000; Kamper
et al, 2009; Zhu et al, 2004; Song et al, 2009). A convincing volume of literature supports a
role for oxidative stress in both behavioral stress and heart disease (Jones, 2008; Akki et al,
2009; Masood et al, 2008; Bouayed et al, 2007; Liu et al, 1996; Liu et al, 2003; Nadeem et al,
2006; Ahlbom et al, 2000; Kamper et al, 2009; Zhu et al, 2004; Song et al, 2009). Oxidative
stress results from an imbalance between the production of reactive oxygen species (ROS)
and the anti-oxidant capacity of the cell. The most widely accepted principle source of ROS is
the mitochondrial electron transport chain. Electrons are transferred in a series of
thermodynamically favorable steps to form H2O and ATP from O2. This is a highly efficient
system but still leads to the production of oxygen with highly reactive unpaired electrons (e.g.
superoxide, hydroxyl radical) and hydrogen peroxide. In addition, oxygen can interact with
nitric oxide (NO) to form peroxynitrite and other reactive nitrogen species. Other potential
sources of ROS include NADPH oxidase, cytochrome P450 and xanthine oxidase. Potent
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antioxidant enzyme systems have evolved to prevent oxidative damage. These include
superoxide dismutase, catalase and glutathione peroxidase. A delicate balance exists between
the production of intracellular oxidants and anti-oxidants to maintain cellular homeostasis.
Enhanced oxidation and/or inadequate reducing capacity results in uncontrolled free radicals
and oxidative stress (Zafarullah et al, 2003; Atkuri et al, 2007).
P38 MAP Kinase:
An important relationship between p38 MAP kinase in the brain and behavioral stress has
been reported (Bruchas et al, 2007). A major characteristic of depression, dysphoria, was
produced in a murine model by activation of p38 MAP kinase by opioid receptors. These and
other animal studies provide the idea that enhanced oxidative stress and p38 MAP kinase
activation can cause mood disorders, and are not simply a consequence of disordered mood. This
concept indicates that patients who suffer from both depression and heart disease may share a
common underlying biological defect that results in enhanced oxidative stress and p38 MAP
kinase activation in both the CNS and myocardium (Jones, 2008; Masood et al, 2008; Bruchas et
al, 2007; Li et al, 2009).
RyR2:
Possible molecular mechanisms linking oxidative stress to myocardial dysfunction
include redox-mediated changes in myocardial excitation contraction coupling (E-C Coupling).
The cardiac myocyte sarcoplasmic reticulum (SR) calcium release channel ryanodine receptor
(SRCRC2; RyR2) plays a central role in this process (Kushnir and Marks, 2010; Prosser et al,
2010; Shan et al, 2010a; Shan et al, 2010b; Gonzalez et al, 2010; Tang et al, 2010). E-C coupling
begins with electrical depolarization of the cardiac myocte that allows a minute quantity of
extracellular calcium to traverse the sarcolemmal L-type calcium channel (LTCC) to activate the
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RyR2 to release a much larger quantity of SR calcium into the cytoplasm. The cytoplasmic Ca2+
then binds to Troponin C enabling actin-myosin binding and sliding of the myofilaments
resulting in sarcomere shortening and myocardial contraction. The calcium is sequestered back
into the SR through the energy-dependent sarco-endoplasmic reticulum calcium ATPase
(SERCA-2) (Kushnir and Marks, 2010; Prosser et al, 2010). Thus, a direct relationship exists
between the capacity of the SR to release and sequester calcium and the force of myocardial
systolic contraction and diastolic relaxation. Dr. Guy Salama at UPMC was the first to describe
redox regulation of the RyR2 through reactive disulfides (Prabhu and Salama, 1990). A defect in
sulfhydryl gating of the RyR2 in a genetic hamster cardiomyopathy model using the sulfhydryl
donor, N-acetylcysteine (NAC) was then reported (Finkel et al, 1993). A defect in dystrophin
was subsequently shown by others to be responsible for the genetic hamster cardiomyopathy
(Sakamoto et al, 1997). NAC has also recently been shown to be cardioprotective in the mdx
dystrophin mouse model of muscular dystrophy (Williams et al, 2007). The mechanism of the
benefit of NAC was not explained. However, NAC did not reduce free radical generation by
NADPH (Williams et al, 2007). An alternative possibility is an effect of NAC on sulhydryl
regulation of RyR2. This possibility has been suggested by recent reports of the pathogenic role
of phosphorylation, nitrosylation, and oxidation of RyR2 in cardiomyopathies and heart failure
(Kushnir and Marks, 2010; Prosser et al, 2010).
Prenatal Stress (PS) Rat Model:
Prenatal stress is defined as “stress experienced by the pregnant mother which affects the
development of the offspring” (Braastad, 1998). In late pregnancy, the hypothalamic-pituitaryadrenal (HPA) axis is hyporesponsive to stressors and the fetus is protected from maternal
glucocorticoids

by

placental

11β-hydroxysteroid
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dehydrogenase

type

2

(inactivates

corticosterone) (Mastorci et al, 2009). However, with repeated exposure to stress these defensive
mechanisms fail, resulting in programming of the offspring’s HPA axis due to transplacental
crossing of glucocorticoids (Burnton, 2010; Maccari & Fletcher, 2007; Barbazanges et al, 1996).
The prenatally stressed rat has gained acceptance as an animal model for mood disorders because
it shares important characteristic behavioral, anatomical and biochemical features with patients
suffering from post-traumatic stress disorder (PTSD) and major depressive disorder (MDD)
(Fride et al, 1988; Weinstock et al, 1988; Takahashi et al, 1988; Takahashi et al, 1990; Fride et
al, 1986; Weinstock et al, 1998; Cratty et al, 1995; Weinstock, 1997; Coplan et al, 1996).
Increased fearfulness and avoidance behaviors; anatomical alterations in the amygdala and
biochemical changes in the HPA axis are shared by this animal model and patients with PTSD
and MDD (Fride et al, 1988; Weinstock et al, 1988; Takahashi et al, 1988; Takahashi et al, 1990;
Fride et al, 1986; Weinstock et al, 1998; Cratty et al, 1995; Weinstock, 1997; Coplan et al,
1996).
Offspring of dams that are subjected to stressful stimuli in their third trimester of
pregnancy (PS) show behavioral disturbances indicative of increased fearfulness (Fride et al,
1988; Weinstock et al, 1988; Takahashi et al, 1988; Takahashi et al, 1990; Fride et al, 1986;
Weinstock et al, 1998; Cratty et al, 1995; Weinstock, 1997; Coplan et al, 1996). Compared to
control rats, adult prenatally stressed offspring display increased anxiety-related behaviors,
including decreased locomotion and exploration and increased freezing when exposed to
novelty (Wakshlak et al, 1990; Vallée et al,1997; Tazumi et al, 2005), suppressed open arm
exploration in the elevated plus maze (Zimmerberg and Blaskey,1998; Vallée et al,1997;
Brunton & Russell,2010), increased defensive withdrawal (Ward et al, 2000), a decreased
tendency to play (Takahashi et al,1992), and altered social interactions (Schneider, 1992;

6

Clarke & Schneider, 1993). Various modifications of the PS rat paradigm have been
developed using different specific stressors including immobilization (Deminiére et al,1992;
Henry et al,1994; Ward & Weisz,1984; Frye & Orecki, 2002), noise (Fride &
Weinstock,1984), electric shocks (Takahashi & Kalin,1991; Estanislau & Morato, 2005),
hypoxia (Fan et al, 2009), immune challenge (Nilsson et al,2001), temperature changes
(Tazumi et al, 2005), saline injection (Ward et al, 2000), or a combination of stressors
(Koenig et al,2005; Richardson et al,2006). A common feature of adult PS offspring is
enhanced sympatho-adrenal activation in response to stressful stimuli (Fride et al, 1988;
Weinstock et al, 1988; Takahashi et al, 1988; Takahashi et al, 1990; Fride et al, 1986;
Weinstock et al, 1998; Cratty et al, 1995; Weinstock, 1997; Coplan et al, 1996). These
stressors cause a rise in corticotrophins and glucocorticoids in the dam (Takahashi et al, 1998;
Williams et al, 1999). The fetal HPS axis responds to maternal stress during late gestation
(Ohkawa et al, 1991; Williams et al, 1999), with the fetal adrenal glands able to secrete
corticosterone from embryonic day 16 (Ohkawa et al,1991; Williams et al, 1999). The altered
behavioral responses of PS offspring to novelty are likely due to increased or prolonged
activity of the HPA axis due to impaired negative feedback of glucocorticoids (Braastad,
1998; Maccari and Fletcher, 2007; Mastorci et al, 2009)
Birkle developed one such model to study the effects of behavioral stress on the
developing, juvenile and adult brain using PS rats (Cratty et al, 1995; Ward et al, 2000; Salm
et al, 2004). Her data have shown that stressing pregnant rats with handling, daily saline
injection and exposure to a novel environment during the last week of gestation (G14-G21)
produced offspring (PS) that are more susceptible to the behavioral and neuroendocrine
effects of stress as adults.

These offspring have enlarged adrenal glands, elevated

7

corticotropin releasing factor (CRF), elevated circulating corticosterone levels, increased heart
rates, and enlarged brain amygdalae (involved in processing and expressing emotions)
compared with offspring of non-stressed dams (Cratty et al, 1995; Ward et al, 2000; Salm et
al, 2004). Behaviorally, Birkle’s prenatal stress model results in offspring that are
hyper-responsive to anxiety-provoking stimuli (e.g. increased defensive withdrawal in a novel
environment and following restraint stress), an essential characteristic of the prenatal stress
syndrome (Fride et al, 1988; Weinstock et al, 1988; Takahashi et al, 1988; Takahashi et al,
1990; Fride et al, 1986; Weinstock et al,1998; Cratty et al, 1995; Weinstock, 1997; Coplan et
al, 1996; Ward et al, 2000; Salm et al, 2004).
In addition, Birkle has shown that PS offspring have elevated concentrations of the
anxiogenic neuropeptide, CRF, as early as postnatal day 1 (P1) in the hypothalamus, and by
postnatal day 14 (P14) in the amygdale (Ward et al, 2000). She also reported a
neuroanatomical defect in the amygdala of this rat model of prenatal stress (Salm et al, 2004).
A defect in the amygdala in these PS rats may explain how a relatively modest behavioral
stressor, such as restraint, could activate potent survival signaling pathways. The amygdala
receives input from brainstem serotonergic pathways and communicates with the
hypothalamus. An increasing volume of basic and clinical literature supports an essential role
for the amygdala in determining an individual’s response to perceived external threat
(Chrousous and Gold, 1992; Adolphs et al, 1995; Hariri et al, 2002). Anxiety, emotional
stress and depression have each been shown to be sufficient to alter the regulation of the
hypothalamic-pituitary adrenal (HPA) hormone system (Chrousous and Gold, 1992; Adolphs
et al, 1995; Hariri et al, 2002; Nemeroff et al, 1984; Veith et al, 1994; Krantz et al, 1991;
Jiang et al, 1996; Tafet et al, 2001). Patients with post-traumatic stress disorder (PTSD) and
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major depressive disorder (MDD) have been shown to have elevated corticotropin releasing
factor (CRF) in their cerebrospinal fluid, altered circulating plasma cortisol, and an
attenuation of the pituitary adrenocorticotropin hormone (ACTH) response to CRF
(Chrousous and Gold, 1992; Adolphs et al, 1995; Hariri et al, 2002; Nemeroff et al, 1984;
Veith et al, 1994; Krantz et al, 1991; Jiang et al, 1996; Tafet et al, 2001). Many patients with
PTSD or MDD also have high baseline circulating catecholamines combined with an
exaggerated increase of these neurotransmitters in response to acute emotional stress
(Chrousous and Gold, 1992; Adolphs et al, 1995; Hariri et al, 2002; Nemeroff et al, 1984;
Veith et al, 1994; Krantz et al, 1991; Jiang et al, 1996; Tafet et al, 2001).
Previous Studies
Adopting Birkle’s PS model, offspring were obtained by breeding virgin male
(Sprague-Dawley, 250-350 g) and female rats (Sprague-Dawley, 225-250 g). Maternal stress
was induced by daily subcutaneous saline injections into skin folds behind the neck (0.9%, 1
ml) at different times of day and moving to a new cage from gestational days 14 through day
21, as previously reported (Kan et al, 2005; Chen et al, 2009). As adults, comparing offspring
that had not been presented with a stressor, no significant differences were found using
echocardiography or in vivo hemodynamics between male offspring of stressed dams and
non-stressed dams. Both groups were subsequently subjected to behavioral stress at 42 and
again at 49 days of post-natal age (Fig. 1). Behavioral stress was produced by restraint for two
hours at room temperature in translucent plastic tubes under normal room light. The animal’s
heads were exposed, but they were unable to back up or turn; and they had limited lateral
mobility. Therefore, studies presented here are based on comparisons between male PS rats
(i.e. born from dams stressed during pregnancy) following restraint stress at 6 and 7 weeks of
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age (Stress) versus age-matched male rats (born from non-stressed dams) following the same
restraint stress at 6 and 7 weeks of age (Control).

Figure 1: Flow diagram
illustrating the steps involved in
generating this prenatal stress
animal model

Stress rats consistently revealed a decrease in systolic function, as reflected in percent
fractional shortening (% FS) by echocardiography following 2 episodes of restraint stress that
were spread a week apart, as indicated in Figure 2 (Control = 61.9 ± 2.4 vs. Stress = 45.8 ±
3.9; P< 0.01; n=12). Adult rat ventricular myocytes (ARVM) isolated from Stress rats also
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revealed diminished % FS compared with Controls, as determined by automated border
detection (Controls = 14.1±2.9 vs. Stress = 8.2±1.3; P< 0.01; n=12) (Fig.3).
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Figure 3

Bar graphs illustrating percent Fractional
shortening (%FS) determined by
echocardiogram. (61.9 ± 2.4 vs. 45.8 ±
3.9, Control vs. Stress; P< 0.01; n=12)

Bar graphs illustrating contractile function of
adult rat ventricular myocytes reflected as %FS
(14.1±2.9 vs. 8.2±1.3, Control vs. Stress; P< 0.01;
n=12)

P38 MAP kinase is a central component of signaling pathways activated in response to
infectious and ischemic stress (Johnson et al, 2002; Shi and Gaestel, 2002). Activation of p38
MAP kinase reversibly depressed cardiac myocyte contractility in vitro (Kan et al, 2004). The
addition of the p38 MAP kinase inhibitor, SB 203580 (10-5 M), reversed the depression in % FS
seen in ARVM from Stress (Figure 4; 8.2 ± 1.3 vs. 13.3±1.7; p<0.01; n=12).

SB 10 µM

Bar graph illustrating the
reversal of the myocardial
depressant effects of Stress
with the p38 MAP kinase
inhibitor, SB-203580 (8.2 ± 1.3
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SB; p<0.01; n=12)
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Echocardiography in patients is considered “non-invasive” because no drugs or trauma
are required. However, echocardiography in animal models requires general anesthesia which
may affect the results. Accordingly, our lab acquired a technique that allowed hemodynamic
monitoring in freely ambulatory awake rats following initial insertion of catheters under general
anesthesia. The use of the more sensitive catheter-based technique showed systolic (+dp/dt),
diastolic (-dp/dt) dysfunction as well as a decrease in left ventricular systolic pressure (LVSP) in
Stress versus Control offspring (Fig. 5 A-C). The p38 MAP kinase inhibitor, SB-203580
(5mg/kg) was injected (i.p.) 24 hours before catheter surgery in accordance with previously
published reports demonstrating in vivo inhibition of p38 MAP kinase enzymatic activity
(Joyeux et al, 2000). Injection of SB 203580 normalized baseline +dp/dt, LVSP and –dp/dt in
Stress compared with Control (Stress + SB vs. Stress; p<0.05; Stress + SB vs. Control; P=NS,
for each), while having no effect on Control vs. Control +SB (P=NS; Figure 5 A-C, below).
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Figure 5
Bar graphs illustrating reversibility of impaired systolic (+dp/dt, A; LVSP,B) and diastolic
(-dp/dt,C) function by the p38 MAP kinas e inhibitor, SB203580 (*p<0.05, Stress vs. Stress
+ SB, n=6-8)

The selective phosphorylation of p38 MAP kinase in Stress rats (and not Controls) and its
inhibition by SB203580 was confirmed by Western blot analysis (Figure 6). We and others have

12

previously reported a calcium-independent negative inotropic effect of p38 MAP kinase in
cardiac myocytes (Kan et al, 2004). The calcium independence of an inotropic effect may be the
result of a phosphorylation-mediated decrease in the affinity of contractile proteins for calcium
(Takeishi et al, 1998; Kaye et al, 1999). Interestingly, we found an increase in Troponin I
phosphorylation in Stress cardiac myocytes that was reversed by in vitro treatment with the p38
MAP kinase inhibitor, SB 203580 (Figure 6).
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Figure 6
Representative Western Blot (A) and densitometry analysis (B) showing increased phosphorylated
p38 MAP kinase and troponin I in Stress vs. Control cardiac myocytes. The p38 MAP kinase
inhibitor SB reversed the increase in phosphorylation of both p38 MAP kinase and troponin I in
Stress. (**p<0.01, *p<0.05 vs. Control; #p<0.05 vs. Stress)
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Materials and Methods

Stress Paradigm: Virgin six-week-old male and female Sprague Dawley rats were purchased
from Hilltop Lab Animals, Inc. These animals were then housed in the CDC/NIOSH animal
quarters. Male rats were used repeatedly for breeding while females experienced only one
gestation. Animals were left alone for a week to allow for acclimation to their new environment
before males and females were paired. The presence of a vaginal plug confirmed mating and
counted as day 1 of pregnancy. The animals were then separated. Control dams were left
undisturbed throughout gestation expect for normal cage changes (about once a week). Stressed
dams were left undisturbed for the first two weeks of gestation except for normal cage changes.
During the third and last week (days 14 to day 21), the stressed dam was removed from her cage,
received a saline injection (0.9%, 1 ml sc) in the folds of skin on the back of the neck, was
placed in a new cage and moved to a new location on the cage rack. After parturition, the dam
and pups (of both groups) were left undisturbed until weaning except for normal cage changes.
Pups were weaned at 3 weeks of age when they were separated from the dam and placed into
cages of 2-3 same sex siblings. Only the male offspring were used for experiments. Starting at 6
weeks of age, male offspring (control and prenatally stressed) were placed in a clear, plastic
restrainer for two hours and then again a week later (Fig. 1 ). During restraint the animal was
unable to back up or turn and had limited lateral mobility. The day after the second restraint
session, the offspring were transported from the CDC/NIOSH animal quarters to the WVU
Health Science Center loading dock and then to the lab for the experimental procedures. “Stress”
rats are defined as offspring of stressed dams and that were subjected to 2 successive restraint
stresses. “Control” rats are offspring of dams that were undisturbed throughout pregnancy, and
that were subjected to the identical restraint stress. All offspring were restrained as adults; the
difference between the two groups is whether the mother was stressed during gestation. All
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experiments were performed the day of transport to the WVU Health Science Center. This study
was performed in accordance with the protocol approved by both the Animal Care and Use
Committees at the National Institute of Occupational Safety and Health (NIOSH) and West
Virginia University.
Isolation of adult rat ventricular myocytes: Cells were isolated from the hearts of adult male
Sprague-Dawley rats, as previously reported (Kan et al, 2005; Chen et al, 2009). Rats were
anesthetized with pentobarbital sodium at 50mg/kg, and the hearts were removed rapidly and
perfused with Krebs-Henseleit bicarbonate buffer (KHB) containing (in mM) 118.1 NaCl, 3.0
KCl, 1.8 CaCl2, 1.2 MgSO4, 1.0 KH2PO4, 27.3 NaHCO3, 10.0 glucose, and 2.5 pyruvic acid,
pH 7.4, according to the method of Langendorff at a constant rate of 8 ml/min with a peristaltic
pump. All buffer and enzyme solutions used during cell isolation were maintained at 37°C and
preequilibrated with 95% O2-5% CO2. Hearts were perfused with KHB for 15 min, followed by
change to low-Ca2+ KHB containing (in mM) 105.1 NaCl, 3.0 KCl, 0.01 CaCl2, 1.2 MgSO4, 1.0
KH2PO4, 20.0 NaHCO3, 10.0 glucose, 5.0 pyruvic acid, 10.0 taurine, and 5.0 mannitol, pH 7.4,
for an additional 10 min. Hearts were then immersed in recirculating KHB with low Ca2+
containing Liberase TM (1.25 mg/ml; Roche Diagnostics, Mannheim, Germany) for 20 min. The
ventricles were minced and placed into a 50-ml centrifuge tube, followed by dissociation of cells
and debris with vigorous pipetting. The concentration of Ca2+ in KHB was increased in four
increments (0.05, 0.4, 0.8, 1.2 mM). The resultant mixture was passed through 225-µm nylon
mesh and centrifuged at 50 g for 2 min. The centrifuge procedure was repeated until the
preparation was composed of at least 80% viable left ventricular myocytes. The myocytes
exhibited typical striated and rod-shaped appearance when viewed by light microscope. Only
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those myocytes that were rod shaped, with striations, no blebs and were not spontaneously
contracting were used for analyses (Kan et al, 2005).
Cardiac Myocyte Contractile Function: Measurements of the amplitude and velocity of
unloaded single cardiac myocyte shortening and re-lengthening were made on the stage of an
inverted

phase-contrast

microscope

(Olympus,

IX70-S1F2)

using

Myocyte

Calcium

Imaging/Cell Length System in which the analog motion signal was digitized and analyzed by
EDGACQ edge detection software (Ionoptix Corp.), as previously reported (Kan et al, 2005;
Chen et al, 2009). A coverslip with attached cells was placed in a temperature-controlled (370C)
chamber (Series 20 Recording/Perfusion Chambers, Warner Ins. Corp.) and continuously
superfused at 0.2 ml/min with KHB buffer. One cell per coverslip was used. Electrical field
stimulation was applied at 0.5 Hz and about 8 volts to achieve threshold depolarization.
Experiments were performed at 20% above threshold. Each cell served as its own control by
continuous superfusion of buffer and drugs. Cell shortening and re-lengthening were assessed
using the following indices: percent peak shortening (%PS), maximal velocities of shortening
(+dl/dt) and re-lengthening (-dl/dt), respectively.
Intracellular calcium measurements: For the measurement of changes in intracellular calcium
concentrations, myocytes were incubated with 1µM Fura-2-am for 40 min, followed by washing
twice and 20 min de-esterification. The cells were alternatively illuminated at 340 and 380 nm at
a frequency of 140 Hz. Emission for each excitation wavelength was filtered at 510 nm. The
ratio of 340/380 ratio represented the concentration in intracellular calcium concentration.
Steady-state responses of ventricular myocytes to electrical-field stimulation under control and
test conditions were recorded from different cells. Only rod-shaped myocytes with clear edges
and no spontaneous contraction were used. Intracellular calcium changes, release and reuptake
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were assessed by change of Fura-2 ratio, Fura-2 Departure Velocity and Fur-2 Return Velocity,
respectively.
To detect the response to increasing concentrations of the beta-adrenergic agonist, isoproterenol,
doses of 10-10, 10-9, 10-8, and 10-7 M were used. To measure the response to increasing
extracellular calcium concentration, doses of 0.5, 1, 2, 3 and 4 mM were applied.
Response to Caffeine treatment: Cardiac myocytes were perifused with 10mM caffeine for 1
min, and then followed by 30-min perfusion of KHB alone or with NAC (0.5, 1, 2, 3, and 4 mM,
respectively).
ATP concentration in heart tissue: Rats were anesthetized with sodium pentobarbital at
50mg/kg and the hearts removed rapidly and perfused with phosphate-buffered saline (PBS).
Trichloroacetic acid (TCA) 10% was added to extract the ATP on ice, homogenized and
centrifuged at 2000×g for 10 mins. The supernatant was diluted with 50 mmol/L Tris-acetate
buffer containing 2 mmol/L ethylenediaminetetraacetic acid (EDTA) (pH 7.75) to a final
concentration of 0.1%. Cardiac ATP content was measured using ENLITEN ATP assay system
(Promega, Madison, WI, USA) according to the manufacturer’s protocol.
GSH/GSSG concentration in cardiac myocytes: Isolated cardiac myocytes were incubated for
60 mins in KHB vehicle alone, or with 10-3M NAC in KHB. Myocytes were washed once with
KHB, and then lysis buffer (50mM HEPES, 1Mm EDTA) was added followed by
homogenization and centrifuging at 10,000×g for 15min at 40C. Supernatant was diluted fivefold
and GSH/GSSG concentration ratio was measured by commercial glutathione assay kit (Cayman
chemical, MI, USA), according to the manufacturer’s protocol.
Plasma Catecholamine Concentrations: A blood sample of 900µl was collected in a microfuge
tube with 100µl of 3.8% sodium citrate after rats were anesthetized by pentobarbital (50 mg/kg).
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The blood sample was centrifuged at 1,000×g for 10 min at 4°C. The plasma was transferred to a
new centrifuge tube and stored at –70oC for analysis. Plasma norepinephrine (NE) and
epinephrine (EPI) were extracted with ESA plasma catecholamine kit (ESA, Inc., Chelmsford,
MA 01824, USA) according to the manufacturer’s instruction. Separation and quantitation of NE
and EPI were accomplished by HPLC with electrochemical detection (Coulochem II, ESA, Inc.,
Chelmsford, MA 01824, USA). The column used was an ESA HR-80 (80 x 4.6 mm) with the
potential conditions, 200mV for the conditioning cell, 100mV for E1 and -100 mV for E2. The
mobile phase (ESA, CAT-A-Phase II) flow was at 1.2 ml/min. Data were analyzed by Waters
Millennium 32 software and enabled accurate determination of noradrenaline and adrenaline.
Statistical Methods: Values are expressed as means± SE. Myocyte data represent the means ±
SE of 15 different determinations derived from 3 individual myocytes from each of 5 different
rats. Students t-test was used to compare catecholamine, ATP, GSH, GSSG, and GSH/GSSG
ratio levels with 10 rats per group. Two-way ANOVA with repeated measures was used to
compare the values measured in the groups. Statistical significance was accepted at the level of
p<0.05.
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Results
The two prevailing hypotheses for reversible myocardial dysfunction following
behavioral stress are enhanced adrenergic stimulation and/or defective nitric oxide vascular
reactivity (Bybee and Prasad, 2008; Wittstein et al, 2005; Richard, 2011). These two hypotheses
are not mutually exclusive and could be related to enhanced oxidative stress. Accordingly, we
compared circulating plasma catecholamine concentrations between Stress and Control the day
after their second restraint (Fig 7). Both norepinephrine and epinephrine were significantly
higher in the Stress compared with Control rats following exposure to the same restraint
paradigm (p<0.01). We also compared ATP concentrations as an indication of mitochondrial
function. ATP was significantly lower in Stress compared with Controls (Fig 8; p<0.01).
Glutathione (GSH) is a tripeptide intracellular antioxidant that plays a central role in cellular
homeostasis (Atkuri et al, 2007). We compared the relative oxidized (GSSG) and reduced (GSH)
states of glutathione to assess the redox status of our model the day after their second restraint
(Fig 9). Stress revealed significantly higher oxidized glutathione (GSSH) and lower ratio of
GSH/GSSG compared with Controls (p<0.01).
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Figure 7: Bar graphs depicting plasma norepinephrine (NE) (1.99±0.29 vs. 11.13±0.55 ng/ml, con
vs. stress, **p<0.01; n=10) (A); and epinephrine (EPI) (7.60±0.80 vs. 21.01±1.02, Con vs. Stress,
**p<0.01; n=10) (B).
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levels measured in extracts from
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(5.16±0.36 vs. 2.42±0.16 µM/g total
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N-acetylcysteine (NAC) has been shown to raise intracellular concentrations of reduced
glutathione by providing an additional source of cysteine as a precursor (Choy et al, 2010; Han et
al, 2010; Kerksick and Willoughby, 2005), to reduce disulfide bonds (Harada et al, 2004), and
scavenge free radicals (Kelly, 1998). Accordingly, we compared the inotropic effects of NAC on
Stress and Controls (Fig 10). NAC (10-3) completely normalized the decrease in % PS in Stress
to Control values without affecting Controls (p<0.01).
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Figure 10: Baseline percent peak
shortening (%PS) in control and stress
myocytes with and without the
-3
addition of NAC (10 M) (11.78±0.34
vs. 7.09±0.38 %, Con vs. Stress,
**p<0.01; 7.09±0.38 vs. 12.34±0.59
%, Stress vs. Stress+NAC, ##p<0.01;
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Blunted/attenuated inotropic response to adrenergic stimulation is one of the hallmark
characteristics of virtually all cardiomyopathies (Kan and Finkle, 2003). Our laboratory has
previously shown in both in vitro and in vivo experiments that Stress shares this cardiomyopathy
feature. (Kan et al, 2005; Chen et al, 2009). Accordingly, we sought to determine if adding NAC
would reverse the blunted inotropic responses of Stress to the beta adrenergic agonist,
isoproterenol (ISO) (Fig 11). NAC completely normalized the concentration-response curves to
increasing concentrations of ISO for total % PS, +dl/dt and –dl/dt (p<0.01 for each).
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Figure 11: Graphic depiction of the response of
cardiac myocytes to increasing concentrations of the
beta-adrenergic agonist, isoproterenol, alone and
with incubation with NAC (10-3 M) on percent peak
shortening (%PS) (Con vs. Stress, p<0.01; Stress vs.
Stress + NAC, p<0.01; n=15) (A), positive inotropy
(+dl/dt) (Con vs. Stress, p<0.01; Stress vs. Stress +
NAC, p<0.01; n=15) (B), and negative inotropy (dl/dt) (Con vs. Stress, p<0.01; Stress vs. Stress +
NAC, p<0.01; n=15) (C).

Isoproterenol mediates its inotropic effects through regulation of intracellular calcium
signaling in cardiac myocytes through stimulation of the beta-receptor (Kan and Finkel, 2003).
Accordingly, we measured the effect of NAC on intracellular Ca2+ responses to ISO (Fig 12).
We confirmed that the NAC mediated inotropic effects were associated with
reversing/normalizing the blunted Ca2+ responses to ISO (p<0.01).
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Figure 12: Graphic depiction of the response of
cardiac myocytes to increasing concentrations of
the beta-adrenergic agonist, isoproterenol, alone
-3
and with incubation with NAC (10 M) on:
2+
change in Ca concentration (Con vs. Stress,
p<0.01; Stress vs. Stress + NAC, p<0.01; n=15)
2+
(A), Ca departure velocity (Con vs. Stress,
p<0.01; Stress vs. Stress + NAC, p<0.01; n=15)
2+
(B), and Ca return velocity (Con vs. Stress,
p<0.01; Stress vs. Stress + NAC, p<0.01; n=15)
(C).

Chen et al (2012) has recently reported that NAC reversed/normalized the blunted
inotropic response of cardiac myocytes to extracellular calcium using a genetic cardiomyopathy
model. We now report that NAC similarly reversed/normalized the blunted inotropic and
intracellular calcium responses to extracellular calcium (Figs 13 &14; p<0.01, for each).
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Figure 13: Graphic depiction of the response of
cardiac myocytes to increasing concentrations of
2+
extracellular Ca alone and with incubation
-3
with NAC (10 M) on percent peak shortening
(%PS) (Con vs. Stress, p<0.01; Stress vs. Stress
+ NAC, p<0.01; n=15) (A), positive inotropy
(+dl/dt) (Con vs. Stress, p<0.01; Stress vs. Stress
+ NAC, p<0.01; n=15) (B), and negative
inotropy (-dl/dt) (Con vs. Stress, p<0.01; Stress
vs. Stress + NAC, p<0.01; n=15) (C) .
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Figure 14: Graphic depiction of the response of
cardiac myocytes to increasing concentrations of
2+
extracellular Ca alone and with incubation with
-3
2+
NAC (10 ) on : change in Ca concentration
(Con vs. Stress, p<0.01; Stress vs. Stress + NAC,
2+
p<0.01; n=15) (A), Ca departure velocity (Con
vs. Stress, p<0.01; Stress vs. Stress + NAC,
2+
p<0.01; n=15) (B), and Ca return velocity (Con
vs. Stress, p<0.01; Stress vs. Stress + NAC,
p<0.01; n=15) (C).

It has been previously proposed that NAC mediates inotropic effects through the
sarcoplasmic reticulum calcium release channel (SRCRC; RYR2) (Finkel et al, 1993; Chen et al,
2012). Caffeine is well-known to cause release of SR calcium (Gaburjakova & Gaburjakova,
2006). Accordingly, we compared the inotropic and calcium regulatory effects of caffeine on
Stress and Controls (Figs 15-26). The addition of caffeine decreased the % PS in cardiac
myocytes from both Stress and Control. (Fig 16A). However, the decrease was greater in the
Stress compared with Controls (16Fig A&B; p<0.01). The same relatively greater effect of
caffeine on Stress compared with Controls was seen in +dl/dt and –dl/dt (Figs 17 &18; p<0.01).
Caffeine also had a greater effect on the release of intracellular calcium in response to electrical
field stimulation in Stress compared with Controls (Figs 19-21). This difference was true when
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measuring total, as well as, rate of release or reuptake of intracellular calcium (p<0.01, for each).
The duration of the inotropic and calcium regulatory effects of caffeine were also longer-lasting
in the Stress compared with Control myocytes (Figs 22&23; p<0.01, for each). This was true for
% PS, +dl/dt, -dl/dt, total calcium, calcium release and reuptake velocities (p<0.01, for each).
The addition of NAC following caffeine significantly reversed both the inotropic and calcium
regulatory effects of caffeine alone (Fig 24-26). This was true for %PS, +dl/dt, -dl/dt, total
calcium, calcium release and reuptake velocities (p<0.01, for each). NAC had no effect on GSH,
GSSG or GSH/GSSG in either Stress or Controls (Fig 27 A-C).

Figure 15: Tracing of control and stress cardiac myocytes contraction right before and after
exposure to caffeine (10mM) (A) and the tracing of intracellular Ca2+ concentration (B).
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Figure 16. Bar graph depicting % PS of control and stress cardiac myocytes before and after exposure to
caffeine (10mM) (10.10±1.27 vs. 6.68±0.77, Con vs. Stress,** p<0.01; 10.10±1.27 vs. 5.8±0.66, Con vs.
Con+Caff, ** p<0.01; 6.68±0.77 vs. 1.88±0.93, Stress vs. Stress+Caff, ## p<0.01; n=15) (A); and percentage
change of control and stress cardiac myocytes after exposure to caffeine (10mM) (44.99±5.75 vs 70.60± 5.09
%, Con vs. Stress, ** p<0.01; n=15) (B). **p<0.01 vs. Control; ##p<0.01 vs. Stress.

Figure 17: Bar graph depicting positive inotropy (+dl/dt) of control and stress cardiac myocytes
before and after exposure to caffeine (10mM) (206.98±10.41 vs. 122.74±11.24, Con vs. Stress,**
p<0.01; 206.98±10.41 vs. 164.10±11.08, Con vs. Con+Caff, ** p<0.01; 122.74±11.24 vs.
67.98±16.04, Stress vs. Stress+Caff, ## p<0.01; n=15) (A); and percentage change of control and
stress cardiac myocytes after exposure to caffeine (10mM) (21.59±3.77 vs 40.96± 3.82%, Con vs.
Stress, ** p<0.01; n=15) (B). **p<0.01 vs. Control; ##p<0.01 vs. Stress.
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Figure 18: Bar graph depicting negative inotropy (-dl/dt) of control and stress cardiac myocytes before and
after exposure to caffeine (10mM) (-126.56±8.06 vs. -53.28±6.84 , Con vs. Stress,** p<0.01; -126.56±8.06
vs. -104.23±9.32 , Con vs. Con+Caff, ** p<0.01; -53.28±6.84 vs. -21.53±8.24, Stress vs. Stress+Caff, ##
p<0.01; n=15) (A); and percentage change of control and stress cardiac myocytes after exposure to caffeine
(10mM) (17.78±2.17 vs. 59.41± 3.46 %, Con vs. Stress, ** p<0.01; n=15) (B). **p<0.01 vs. control;
##p<0.01 vs. stress.

Figure 19: Bar graph depicting change in calcium concentration in control and stress cardiac
myocytes before and after exposure to caffeine (10mM) (0.75±0.12vs. 0.53±0.07, Con vs.
Stress,** p<0.01; 0.75±0.12 vs. 0.57±0.07, Con vs. Con+Caff, * p<0.05; 0.53±0.07 vs.
0.20±0.06, Stress vs. Stress+Caff, ## p<0.01; n=15) (A); and percentage change of control and
stress cardiac myocytes after exposure to caffeine (10mM) (37.72 ± 5.68 vs 60.02±1.04%, Con vs.
Stress, ** p<0.01; n=15) (B). *p<0.05 vs. control; **p<0.01 vs. control; ##p<0.01 vs. stress.
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Figure 20: Bar graph depicting calcium departure velocity in control and stress cardiac myocytes
before and after exposure to caffeine (10mM) (123.60±6.70 vs. 52.90±5.64, Con vs. Stress,** p<0.01;
123.60±6.70 vs. 80.54±8.91, Con vs. Con+Caff, ** p<0.01; 52.90±5.64 vs. 24.19±7.34, Stress vs.
Stress+Caff, ## p<0.01; n=15) (A); and percentage change of control and stress cardiac myocytes after
exposure to caffeine (10mM) (33.65± 6.97 vs 56.74±5.11%, Con vs. Stress, ** p<0.01; n=15) (B).
**p<0.01 vs. Control; ##p<0.01 vs. Stress.

Figure 21: Bar graph depicting calcium return velocity in control and stress cardiac myocytes before and
after exposure to caffeine (10mM) (-99.70±6.88 vs. -49.07±8.07, Con vs. Stress,** p<0.01; -99.70±6.88
vs. -71.94±8.80, Con vs. Con+Caff, ** p<0.01; -49.07±8.07 vs. -25.69±4.52, Stress vs. Stress+Caff, ##
p<0.01; n=15) (A); and percentage change of control and stress cardiac myocytes after exposure to
caffeine (10mM) (23.21±4.42vs 50.88±6.92 %, Con vs. Stress, ** p<0.01; n=15) (B). **p<0.01 vs.
Control; ##p<0.01 vs. Stress.
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Figure 22: Graphic depiction comparing recovery
of stress versus control cardiac myocytes after
exposure to caffeine (10mM). Results are
measured as baseline, caffeine exposure and time
since caffeine exposure: percent peak shortening
(%PS) (p<0.01 control vs. stress) (A); positive
inotropy (+dl/dt) (p<0.01 control vs. stress) (B);
and negative inotrophy (-dl/dt) (p<0.01 control vs.
stress) (C); n=15 myocytes.
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Figure 23: Graphic depiction comparing
recovery of stress versus control cardiac
myocytes after exposure to caffeine (10mM).
Results are measured as baseline, caffeine
exposure and time since caffeine exposure:
2+
change in Ca concentration (p<0.05 control
2+
vs. stress) (A);Ca departure velocity
2+
(p<0.01 control vs. stress) (B); and Ca
return velocity (p<0.01 control vs. stress) (C);
n=15 myocytes.
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Figure 24: Tracing of control and stress cardiac myocytes contraction (A) and
intracellular Ca2+ concentration (B) with 30 minutes of perifusion of KHB
alone or with NAC (10-3M) after exposure to caffeine (10mM).
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Figure 25: Dose response curve of NAC and
its effect on cardiac myocyte recovery after
exposure to caffeine (10mM). Results are
measured as baseline, caffeine exposure, and
30 min. after caffeine exposure with perfusion
in buffer alone or NAC. Different myocytes
were used for each concentration of NAC;
percent peak shortening (%PS) (p<0.01,
control vs. stress) (A); positive
inotrophy(+dl/dt) (p<0.01 control vs.
stress)(B); negative inotrophy (-dl/dt)(p<0.01
control vs. stress)(C); n=15 myocytes for each
concentration of NAC.
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Figure 26: Dose response curve of NAC and its
effect on cardiac myocyte recovery after
exposure to caffeine (10mM). Results are
measured as baseline, caffeine exposure, and
30 min. after caffeine exposure with perfusion
in buffer alone or NAC. Different myocytes
were used for each concentration of NAC;
2+
change in Ca concentration (p<0.01, control
2+
vs. stress) (A); Ca departure velocity (p<0.01
2+
control vs. stress)(B); Ca return velocity
(p<0.01 control vs. stress)(C); n=15 myocytes
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Figure 27: Bar graph depicting the effects of 10-3
NAC on GSH concentration (29.24±4.75 vs.
23.63±3.0, control vs. stress; 28.29±4.07 vs.
30.05±5.42 control + NAC vs. stress +NAC p>0.05
n=15) (A), GSSG concentration (1.23±0.20 vs.
5.46±0.71, control vs. stress ** p<0.01; 1.87±0.44
vs. 6.20±0.94 control + NAC vs. stress + NAC,
##p<0.01 n=15)(B), and on the GSH/GSSG ratio
(23.76±4.20 vs. 17.93±2.30µM/mg , Control vs.
Control +NAC; 5.58±1.42 vs. 4.66±0.52 Stress vs.
Stress + NAC, p=NS; Control vs. Stress **p<0.01;
Control + NAC vs. Stress + NAC, ## p<0.01 n=10)
(C).
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Discussion

A compelling body of basic and clinical literature supports a pathogenic role for
oxidative stress in animal models and human beings with cardiomyopathies and heart failure
(Akki et al; Kuroda et al, 2010). Oxidative stress is said to occur when there is an imbalance
between the production of reactive oxygen species (ROS) and the anti-oxidant capacity of the
cell. Oxidative stress is increased in failing myocardium and studies have implicated redoxmediated mechanisms by ROS in several aspects of myocardial failure (Sawyer et al, 2002).
Prolonged adrenergic stimulation can cause myocardial and systemic oxidative stress, with an
increase in ROS without appropriate increase in antioxidants. Mitochondria are the major source
of ROS due to electron leakage from the electron transport chain to react with oxygen and form
superoxide (Sawyer et al, 2002). Indeed, prolonged β2-adrenoreceptor activation has been
reported to lead to activation of NADPH oxidase, the production of ROS, and p38 MAPK
activation. Treatment with n-acetylcysteine (NAC) prevented p38 MAPK activation, indicating
that p38 MAPK is a downstream target of ROS (Xu et al, 2011). Besides NADPH oxidase,
cytochrome P450 and xanthine oxidase are sources of ROS. Antioxidant enzyme systems are
present to prevent oxidative damage and include superoxide dismutase, catalase and glutathione
peroxidase. A delicate balance exists between the production of intracellular oxidants and antioxidants to maintain cellular homeostasis. Enhanced oxidation and/or inadequate reducing
capacity result in oxidative stress from uncontrolled free radical activation. Such free radical
activation in the heart can cause myocardial contractile dysfunction (Akki et al, 2009; Goldhaber
and Qayyum, 2000; Zima and Blatter, 2006). Stress offspring show signs of myocardial
dysfunction and oxidative stress with reduced ATP levels (Fig.8) and GSH/GSSG (Fig. 9C),
respectively
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Both in vivo and in vitro administration of n-acetylcysteine (NAC) has been shown to
raise intracellular concentrations of reduced glutathione (GSH) by providing an additional source
of cysteine as a precursor (Choy et al, 2010; Han et al, 2010; Kerksich and Willoughby, 2005).
Glutathione is a tripeptide consisting of glutamate, cysteine, and glycine, with cysteine being the
limiting amino acid in the production of glutathione. Glutathione is the main cytosolic redox
buffer in cardiomyocytes with the ratio of reduced glutathione to glutathione disulfide (oxidized
form)(GSH/GSSG) being controlled by the pentose phosphate pathway by providing
nicotinamide-adenine dinucleotide phosphate (NADPH) which is needed by glutathione
reductase to covert GSSG into GSH (Zima and Blatter, 2006; Sawyer et al, 2002). Because GSH
can directly scavenge free radicals including ROS or indirectly through glutathione peroxidase, a
high cytosolic GSH/GSSG ratio is critical for antioxidant defense (Zima and Blatter, 2006).
Besides being a GSH precursor (Zafarullah et al, 2003), NAC can reduce disulfide bonds
(Harada et al, 2004), and scavenge free radicals (Kelly, 1998). Glutathione deficiency occurs in
many diseases due to factors including viral protein-mediated GSH depletion, uncontrolled
inflammatory reactions, and increased generation of free radicals. Clinically, NAC is used as a
mucolytic agent, for acetaminophen overdose, and in disease states characterized by low cysteine
and GSH concentrations like HIV, heart disease, cancer, and pulmonary diseases (Kelly, 1998;
Atkuri et al, 2007; Zafarullah et al, 2003). The doses of NAC used in humans have typically
ranged from 200-1,000 mgs orally daily (Borges-Santos et al, 2012; De Rosa et al, 2000). These
doses have been demonstrated to significantly increase plasma cysteine and GSH, each by
approximately 100 uM (Borges-Santos et al, 2012; De Rosa et al, 2000). Oral NAC doses of
200-400 mg also have been reported to achieve plasma concentrations of 0.35-4 mg/L (BorgesSantos et al, 2012; De Rosa et al, 2000). Accordingly, we used the concentration range of 10-3 to
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10-7M NAC for in vitro experiments based on a molecular weight of 163 and published
pharmacokinetic data in human beings (Holdiness,1991).
Heart failure is characterized by myocardial remodeling, left ventricular dysfunction, and
impaired myocyte calcium handling (Dash et al, 2001; Hasenfuss & Pieske, 2002; Luo et al,
2006). Contraction and force generation in muscle is regulated by cytosolic concentrations of
calcium (Ca2+), which is stored in the sacroplasmic reticulum (SR) and is available for
immediate release into the cytosol. Changes in intracellular Ca2+ handling are associated with
myocardial dysfunction presenting with reduced Ca2+ transient amplitude, increased Ca2+
transient duration, prolonged Ca2+ transient decay time, and decreased SR Ca2+ load (Hobai and
O’Rourke, 2001; Hasenfuss & Pieske, 2002; Houser and Margulies, 2003; Belevych et al, 2007;
Kuster et al, 2010). It is clear that altered myocyte Ca2+ handling is involved in our Stress model
of reversible myocardial dysfunction (Figs.13, 14, 22, 23, 25, 26).
Cardiac contraction consists of an electrical excitation phase followed by a contractile
phase (E-C coupling). Depolarization of the sinoatrial node initiates the electrical phase causing
a wave of depolarization to spread via the conduction system through the atria and ventricles.
The current flows from a depolarized cardiomyocyte to its resting neighbor through gap
junctions. The depolarization of the myocyte allows a small amount of Ca2+ to cross the
sarcolemmal L-type calcium channel (LTCC), where it activates the Ryanodine receptor (RyR2)
to release a larger amount of Ca2+ into the cytoplasm from the SR. The cytoplasmic Ca2+ then
binds to Troponin C, enabling actin-myosin binding and sliding of the myofilaments and
resulting in sarcomere shortening and myocardial contraction. Calcium is returned to the SR
through the sacro-endoplasmic reticulum calcium ATPase (SERCA2), which re-sequesters Ca2+
back into the SR at the expense of ATP. Ca2+ also is removed from the cell through the
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sacrolemmal sodium-calcium exchanger (NCX) and plasmalemmal Ca2+ ATPase to balance the
Ca2+ that entered through the LTCC (Kushnir & Marks, 2010; Zalk et al, 2007; Belevych et al,
2007; Hasenfuss and Pieske, 2002) (Fig. 28). Therefore, expression and activity of the
receptors/transporters of Ca2+ release and uptake are related to the force of myocardial systolic
contraction and diastolic relaxation.

Figure 28: Schematic diagram illustrating the movement of Ca2+ into the myocyte to cause intracellular Ca2+ release
followed by resequestration of Ca2+ back into the sarcoplasmic reticulum (SR) and extrusion back into the extracellular space.
A small amount of Ca2+ enters the myocyte through L-type calcium channels (LTCC) which triggers a large release of Ca2+
from the SR through activation of the Ryanodine receptor (RyR2). Ca2+ is resequestered into the SR by the sacroendoplasmic reticulum calcium ATPase (Ca2+/ATPase; SERCA2). Ca2+ is extruded from the cell largely through the
sodium/calcium exchanger (NCX) and the plasmalemmal calcium ATPase. Contraction can be modulated through the Gprotein coupled beta adrenergic receptor. Binding to the beta-receptor will lead to adenylyl cyclase activation, cyclic AMP
production and PKA activation. The targets of PKA include the LTCC, RYR2, and phospholamban (regulatory protein of
SERCA2). Therefore, beta-receptor activation typically leads to enhanced contraction and relaxation of the myocyte.
(Modified from Kan and Finkel, 2003)
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Two possibilities may explain the altered Ca2+ handling in our model. First, there could
be decreased reuptake of Ca2+ into the SR due to decreased activity of SERCA2 (due to redox
mechanisms of phosphorylation status of phospholamban) with possible increase in activity of
the NCX (increased extrusion of Ca2+ out of the cell helps maintain normal diastolic Ca2+ but
decreases the amount available for SR reuptake). The second possibility is Ca2+ leaking out of
the SR during diastole due to dysfunctional activity of RYR2 (Marx et al, 2000; Hobai and
O’Rourke, 2001; Inesi et al, 2008; Houser and Margulies, 2003; Belevych et al, 2007; Satoh et
al, 2000; Kuster et al, 2010; Luo et al, 2006;Zima et al, 2010). Altered function of these
transporters could explain the reduced percent peak shortening (% PS), positive inotrophy
(+dl/dt), negative inotrophy (-dl/dt), Ca2+ release, departure velocity, and return velocity upon
stimulation with isoproterenol (Figs. 11, 12), extracellular calcium (Figs. 13, 14), and caffeine
(Figs 16-21) in Stress myocytes.
Prenatally stressed (PS) offspring have prolonged, exaggerated responses when presented
with an acute stressor as adults due to impaired negative feedback of their HPA axis (Braastad,
1998; Maccari and Fletcher, 2007; Mastorci et al, 2009). This PS model has been shown to have
increased concentrations of corticotropin-releasing factor (CRF) (Cratty et al, 1995) and
corticosterone (Ward et al, 1999).We now show that this lengthened stress response leads to an
increase in catecholamines in Stress offspring after behavioral stress, as seen by elevated
epinephrine and norepinephrine the day after their second restraint (Fig 7). This is important
because prolonged beta-adrenergic receptor activity is known to result in cardiac hypertrophy,
depressed left ventricular function and premature mortality (Dash et al, 2001).
Catecholamines activate Gs-protein coupled receptors through β adrenergic receptors
leading to PKA activation (Rapacciuolo et al, 2001) and increased cardiac contractility (Zheng,
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et al, 2000). Activated PKA will phosphorylate RyR2, activating the Ca2+ release channel partly
by increasing the sensitivity of RyR2 to cytosolic Ca2+ (Marx et al, 2000). Prolonged
catecholamine signaling, however, is detrimental, leading to increased activation of PKA and
hyperphosphorylation of the RyR2 receptor, Ca2+ leak out of the SR and contractile dysfunction.
This may be due to the dissociation of calstabin2 (a RyR2 regulatory protein), from RyR2 upon
PKA phosphorylation resulting in increased sensitivity of RyR2 to Ca2+ induced activation.
Prolonged increased RyR2 sensitivity to cytosolic Ca2+ leads to inappropriate Ca2+ release during
diastole (Ca2+ leak) and reduces SR Ca2+ stores (Marx et al,2000; Bellinger et al, 2008).
Hyperphosphorylation of RyR2 and the dissociation of calstabin2 uncouples multiple RyRs and
disturbs coupled gating. Coupled gating is important for enabling the opening and closing of
RyRs in a given SR T-tubule junction in a coordinated manner. Uncoupled channels will result in
some channels not closing during diastole and Ca2+ leak (Hasenfuss and Pieske, 2002; Marx et
al, 2001). Reduced phosphatase association with RyR2 could play a role in Ca2+ leak with
decreased inactivation of RyR2 (Marx et al, 2000). Stress animals had reduced concentrations of
ATP (Fig. 8). This could be due to increased SERCA2 activity in an effort to compensate for
Ca2+ leak through RyR2 (Hasenfuss and Pieske, 2002; Bellinger et al, 2008; Zima et al, 2010).
There is evidence that redox mechanisms can affect the activity of several Ca2+
transporters. Salama first described sulfhydryl regulation of the RyR2, where it was seen that
oxidation via cysteine caused formation of disulfide bonds and opening of the channel and SR
Ca2+ release. Conversely, addition of sulfhydryl reducing agents like reduced glutathione (GSH)
reduced the disulphide bonds, regenerating the free SH groups on SR proteins, closing the
channel and activating re-uptake of Ca2+ (Salama et al, 1992; Trimm et al, 1986; Györke and
Carnes, 2008; Zima and Blatter, 2006).Prolonged adrenergic stimulation has been suggested to
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cause myocardial and systemic oxidative stress (Sawyer et al, 2002). Reactive oxygen species
(ROS) are capable of reacting with cysteines causing a conformational change in RyR2 and Ca2+
leak (Terentyev et al, 2008; Belevych et al, 2007; Györke and Carnes, 2008; Zima and Blatter,
2006). SERCA2 may decrease in activity as a result of oxidation by ROS (Scherer and Deamer,
1986; Lancel et al, 2010; Kuster et al, 2010; Zima and Blatter, 2006) while the NCX can be
activated by ROS (Reeves et al, 1986; Goldhaber and Qayyum, 2000; Kuster et al, 2010; Zima
and Blatter, 2006). In addition, p38MAPK is redox-sensitive and is activated by ROS (Saitoh et
al, 2007; Filomeni et al, 2003; Veal et al, 2004). Stress offspring have evidence of mitochondrial
dysfunction and oxidative stress seen by reduced ATP (Fig.8), and GSH/GSSG (Fig. 9C),
respectively. Studies have shown that treatment of control myocytes with an oxidizing agent
weakens the amplitude of Ca2+ transients while treating heart failure myocytes with an
antioxidant increases the amplitude of the Ca2+ transient up to control values. Treatment of
control myocytes with an antioxidant, however, had no effect. These results are consistent with
the idea that reversible oxidation of components of the E-C coupling machinery is minimal in
normal myocytes (Terentyev et al, 2008). This concept agrees with the present results as well;
NAC was able to reverse dysfunction in Stress myocytes but had no effect on Control myocytes
(Figs. 10, 11A-C, 12A-C, 13A-C, 14A-C, 24A&B, 25A-C, 26A-C).
There is a blunted response to the β-adrenergic agonist, isoproterenol, in the Stress model
(Kan et al, 2005; Chen et al, 2009; Figs. 11A-C; 12A-C). This may be because RyR2 is already
PKA hyperphosphorylated and further phosphorylation (through β-adrenergic receptors/Gs
pathway) cannot occur (Marx et al, 2000). Phosphorylation of RyR2 increases the probability
that it will be in the open state; hyperphosphorlyation can result in incomplete channel closure
and allows Ca2+ to leak out of the SR. Therefore, upon stimulation, these myocytes have a lower
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concentration of Ca2+ available for release from the SR compared to normal myocytes (Zalk et
al, 2007; Belevych et al, 2007). Stress myocytes had reduced SR Ca2+ release when stimulated
with isoproterenol or calcium (Figs. 12 A; 14A), NAC (10-3) reversed this defect in the Stress
myocytes without affecting the Control myocytes (Figs. 12 A; 14A). NAC (10-3) also reverses
the positive (+dl/dt) and negative (-dl/dt) inotropic dysfunction in response to isoproterenol and
extracellular calcium (Fig. 11 A-C, 13A-C) in the Stress myocytes without affecting the Control
myocytes. This may occur through redox mechanisms of NAC on RyR2, closing the channel and
stopping the Ca2+ leak.
Catecholamine signaling pathways have been shown to activate mitogen-activated
protein (MAP) kinases, including stress-activated p38 MAPK (Rapacciuolo et al, 2001; Dash et
al, 2003; Xu et al, 2011) with the stimulatory effects of the β2-adrenergic receptor on p38 MAPK
being mediated by a PKA-dependent pathway (Zheng et al, 2000). Upon activation, p38 MAPK
then provides a negative feedback to PKA-mediated positive contractile response (Zheng et al,
2000). We have previously reported in Stress offspring elevated phosphorylated p38 MAPK and
reversibility of myocardial dysfunction with the p38 MAP kinase inhibitor SB-203580 (Kan et
al, 2005; Chen et al, 2009). Activated p38 will phosphorylate an array of intracellular targets
including numerous transcription factors, resulting in reprogramming of gene expression (Liang
& Molkentin, 2003) and cardiac remodeling (Dash et al, 2003). The p38 MAPK pathway can
stimulate hypertrophic growth (Zechner et al, 1997; Wenzel et al, 2005), be pro-apoptotic (Wang
et al, 1998), or anti-apoptotic (Zechner et al, 1998), indicating a significant role for p38 signaling
in cardiac pathologies. Authors of in vivo and in vitro studies have reported that cardiac specific
activation of p38 MAPK markedly attenuates cardiac contractility (Liao et al, 2001; Liao et al,
2002). Increased activation of p38 during prolonged episodes of stress may counterbalance the
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PKA-mediated positive contractile response by decreasing the myofilament responsiveness to
calcium (Liao et al, 2002). Cardiac stress through activation of p38 MAPK may lead to
downregulation of SERCA2 (Andrews et al, 2003).This will result in increased diastolic
intracellular calcium concentration (Andrews et al, 2003). SERCA2 is regulated by
phospholamban. The dephosphorylated form inhibits SERCA2. Phosphorylation of
phospholamban by PKA stimulates SERCA2 activity (Hasenfuss and Pieske, 2002; Dash et al,
2001; Marx et al, 2000). If p38 MAPK feeds back to negatively regulate PKA, decreased
phosphorylation of phospholamban could decrease SERCA2 activity and SR Ca2+ reuptake.
Exposure of myocytes to caffeine sensitizes RyR2 to activation by Ca2+ and leads to a
massive release of Ca2+ from the SR. Caffeine potentiates SR Ca2+ release and myocyte
contraction only transiently because it depletes the SR of Ca2+ (Zalk et al, 2007). After caffeine
exposure, the amplitude of further contractions and SR Ca2+ release will be reduced until the
Ca2+ is returned to the SR through SERCA2. This pattern was seen in myocytes exposed to
caffeine. Caffeine exposure resulted in a spike in contraction and intracellular Ca2+ followed by a
reduction in amplitude of both (Fig. 15 A&B) with return to baseline in Control myocytes within
30 minutes (Fig. 24 A&B). Stress myocytes showed an initial increase followed by a decrease in
amplitude of contraction and intracellular Ca2+ (Fig. 15 A&B) but were unable to return to
baseline within 30 minutes (Fig. 24 A&B). Perifusion of the myocytes with NAC (10-3) after
caffeine exposure allowed the Stress myocytes to return to baseline (Fig. 24 A&B) while having
no effect on the Control myocytes, which were able to return to baseline without NAC (Figs. 24
A&B;). This indicates that the Stress myocytes were not effectively taking Ca2+ back up into the
SR, which would point to decreased SERCA2 activity. However, Ca2+ leak through RyR2 also
could play a role.
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The initial exposure to caffeine caused an increase in contraction and intracellular Ca2+,
followed by a decrease in percent peak shortening (Fig. 16 A), positive inotrophy (+dl/dt) (Fig.
17A), negative inotrophy (-dl/dt) (Fig.18A), SR Ca2+ release (Fig. 19A), SR Ca2+ departure
velocity (Fig. 20A), and SR Ca2+ return velocity (Fig 21A). Baseline values of these 6 variables
were reduced in Stress myocytes compared to Control. The decrease in these variables occurred
in both Control and Stress myocytes. However, the decrease was significantly more pronounced
(p<0.01) in the Stress myocytes (Figs. 16B, 17B, 18B, 19B, 20B, 21B). The Control myocytes
returned to baseline values of all 6 of these variables within 30 minutes (Figs. 22A-C; 23A-C).
The Stress myocytes were not able to return to baseline (Figs. 22A-C; 23A-C). Myocytes were
perifused with NAC after exposure to caffeine. Stress myocytes perifused with the higher
concentrations of NAC (10-5,10-4,10-3) approached baseline values of percent peak shortening
(Fig. 25 A), positive inotrophy (+dl/dt) (Fig. 25B), negative inotrophy (-dl/dt) (Fig.25C), SR
Ca2+ release (Fig. 26A), SR Ca2+ departure velocity (Fig. 26B), and SR Ca2+ return velocity (Fig
26C). NAC had no effect on Control myocytes which were able to return to baseline
spontaneously (Figs. 25 A-C; 26 A-C). Perifusion with the higher concentrations of NAC (105

,10-4,10-3) not only allowed Stress myocytes to return to Stress baseline values but surpassed

them and approached baseline for the Control myocytes (Figs. 25 A-C; 26 A-C). Again, NAC
may be working through redox mechanisms on the Ca2+ channels of the Stress myocytes without
affecting the Control myocytes.
In summary, changes in myocyte Ca2+ handling could be attributed partially to redox
modifications and/or phosphorylation of Ca2+ transporters and/or their regulatory proteins.
Chronically elevated circulating catecholamines can modify these transporters/proteins by
phosphorylation through PKA (Rapacciuolo et al, 2001; Zheng et al, 2000) or by redox
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mechanisms through oxidative stress (Terentyev et al, 2008; Neri et al, 2007; Osadchii, 2007) in
the prenatal stress model. NAC, possibly through redox mechanisms, can reverse the myocardial
dysfunction seen in this model after behavioral stress.
While NAC was able to reverse the dysfunction in Stress myocytes in response to
isoproterenol, extracellular calcium, and caffeine, NAC failed to normalize both GSSG and
GSH/GSSG levels in Stress myocytes (Fig.27). These data indicate that NAC mediates its
inotropic effects independent of increasing GSH and mostly functions through redox
mechanisms in the prenatal stress model. Indeed, reversal of both positive and negative
inotrophy by NAC is consistent with sulfhydryl regulation of RyR2 or SERCA-2. Considerably
more detailed physiologic and biochemical studies will be necessary before drawing any
definitive conclusions regarding which transporters that are affected by NAC in this model.
In conclusion, we have provided compelling evidence of reversal of cardiac myocyte
dysfunction by NAC in a behaviorally stressed cardiomyopathy model. Potential clinical
implications of these data include the possibility that cardiomyopathies may respond to NAC
therapy. NAC therapy is already being explored for treating HIV infection (Roederer et al,
1992).These studies are being conducted based on data indicating enhanced oxidative stress and
decreased glutathione concentrations following HIV infection (Nakamura et al,2002). In fact,
Chen et al (2012) reported reversal of myocardial dysfunction with NAC in a Tat (HIV protein)
transgenic murine model with increased oxidative stress. Further studies are needed to determine
the exact role that NAC is playing and what transporters are being altered in this unique animal
model of behavioral stress induced reversible cardiomyopathy.
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